Cervical, endometrial, ovarian, vulvar, and vaginal cancers affect women of a broad age spectrum. Many of these women are still sexually active when their cancer is diagnosed. Treatment options for gynecological malignancies, such as gynecological surgery, radiation, and chemotherapy, are proven risk factors for pelvic floor dysfunction. The prevalence of urinary incontinence, fecal incontinence, and sexual dysfunction before cancer treatment is still unclear. Hypotheses have been raised in the literature that these manifestations could represent early symptoms of pelvic cancers, but most remain overlooked even in cancer surviving patients.
The primary focus of therapy is always cancer eradication, but as oncological and surgical treatment options become more successful, the number of cancer survivors increases. The quality of life of patients with gynecological cancers often remains an underrated subject. Pelvic floor disorders are not consistently reported by patients and are frequently overlooked by many clinicians. In this brief review we discuss the importance of pelvic floor dysfunction in patients with gynecological malignant tumors.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Bodean, Oana M.; Marcu, Radu D.; Spinu, Dan A.; Socea, Bogdan; Diaconu, Camelia C.; Munteanu, Octavian; Taus, Nicoleta; and Cirstoiu, Monica
"Pelvic floor disorders in gynecological malignancies. An overlooked problem?,"
Journal of Mind and Medical Sciences: Vol. 5
, Article 8.
Available at: https://scholar.valpo.edu/jmms/vol5/iss1/8